48,830
edits
m (→Stage: fxi gr.) |
(→French system: +formal name) |
||
Line 92: | Line 92: | ||
===French system=== | ===French system=== | ||
Overview:<ref name=pmid8996162/><ref name=uscap_stp>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SoftTissue_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SoftTissue_11protocol.pdf]. Accessed on: 12 April 2011.</ref> | *Formally known as the grading system from the ''French Federation of Cancer Centres Sarcoma Group'' (FNCLCC). | ||
====Overview==== | |||
Components - overview:<ref name=pmid8996162/><ref name=uscap_stp>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SoftTissue_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SoftTissue_11protocol.pdf]. Accessed on: 12 April 2011.</ref> | |||
#Differentiation (score 1-3). | #Differentiation (score 1-3). | ||
#*De facto, this is mostly the ''histologic type''. | #*De facto, this is mostly the ''histologic type''. |
edits